Sharenet Sites 
Sharenet Sites
Disposal of Ascendis Pharma – Closing of Austell Pharma Disposal
Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis Health” or “the Company”)
DISPOSAL OF ASCENDIS PHARMA – CLOSING OF AUSTELL PHARMA DISPOSAL
Shareholders are referred to the various announcements relating to the proposed disposal by
Ascendis Health SA Holdings Proprietary Limited, a wholly-owned subsidiary of Ascendis Health,
of its direct and indirect interests in the entities through which the business known as “Ascendis
Pharma” operates to Austell Pharmaceuticals Proprietary Limited, for a base purchase consideration
of R432 million (the “Austell Pharma Disposal”).
Shareholders are hereby advised that Austell Pharma Disposal has become unconditional and has closed
today, 31 October 2022.
The closing of the Austell Pharma Disposal is a key milestone towards creating a sustainable capital
structure for the Company. The proceeds will be applied to discharge the majority of the outstanding
debt and will enable the Company to re-focus its attention on the operations of its remaining businesses
and the various strategic initiatives that are currently underway.
31 October 2022
Johannesburg
Sponsor
Valeo Capital (Pty) Limited
Date: 31-10-2022 04:20:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
